Share this
voices from the field: exploring Harpera’s global impact on dermatological research
by Neoteryx Microsampling on Oct 10, 2024 1:49:10 PM
Explore firsthand accounts from distinguished researchers as they share their groundbreaking work with the Harpera™ Microbiopsy™ Punch. These enlightening interviews have been summarized below for your convenience but to uncover the depth of their studies make sure to click the full transcript link.
Harpera used for skin microsampling in leishmaniasis study
Charles University researchers described their extensive use of the Harpera™ Microbiopsy™ Punch tool in their study of leishmaniasis. Highlighting the tool's minimally invasive nature, crucial for ethical and efficient sampling in their field studies, particularly in endemic regions like Ethiopia and Algeria. Harpera's capability to collect precise skin samples with minimal discomfort has revolutionized their approach, allowing for improved compliance and richer data collection, particularly in remote settings where traditional methods are too cumbersome. To read the full interview click here for the full transcript.
Microbiopsy enables study of atopic dermatitis
In an interview with Drs. Yacine Amar and Martin Köberle from the Technical University of Munich discussed their research on atopic dermatitis and the microbiome's role in its development. They highlight how the gentle sampling nature of Microbiopsy was particularly advantageous in pediatric studies, emphasizing its minimal invasiveness and ability to collect multiple samples over time without distressing the young participants. Enabling repetitive, longitudinal studies critical for understanding the skin condition's pathogenesis. To read the full interview click here for the full transcript.
minimally invasive sampling of skin diseases
Researchers from the Institute of Tropical Medicine discuss their experiences using the Harpera Microbiopsy Punch in field studies on leishmaniasis in Africa and India. They highlight the tool's ability to improve compliance with its minimally invasive sample collection event, enabling early diagnosis and treatment, which is crucial for managing and controlling skin diseases. Consistent sampling and ease of use in sensitive areas make it a valuable asset in dermatological research and public health. To read the full interview click here for the full transcript.
the origin of Harpera™ Microbiopsy™ Punch tool
Discover the origins of the Harpera™ Microbiopsy™ Punch by researchers at the University of Queensland. Designed to facilitate a minimally invasive, rapid skin collection event, Microbiopsy offers a simpler collection method, ideal for remote research. The Harpera tool captures minute skin samples efficiently and is especially suited for sensitive areas and pediatric use. The technology has potential applications across dermatology research, cosmetic testing, and pediatric healthcare, offering a gentler alternative to traditional biopsies while enabling frequent, precise sampling for longitudinal studies. To read the full interview click here for the full transcript.
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (74)
- Therapeutic Drug Monitoring, TDM (51)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Blood Microsampling, Serology (22)
- Decentralized Clinical Trial (DCT) (22)
- Omics, Multi-Omics (20)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- December 2024 (2)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think